Skip to content

Peptide library / Hormones & metabolism / Somapacitan

FDA-approvedHormones & metabolism

Somapacitan

A once-weekly growth hormone for children and adults with growth hormone deficiency.

Body system
Hormones & metabolism
Status
FDA-approved
Strongest evidence
FDA approved
Also known as
Sogroya

Effects studied or claimed

What it is used or promoted for, and where each effect has actually been seen

  • Growth hormone deficiency in adults and childrenFDA approved

How it is thought to work

Somapacitan binds blood albumin, so one injection lasts a week instead of a day.

What the evidence shows

Trials showed growth comparable to daily somatropin in children.

Safety and unknowns

Similar to daily growth hormone: headache, joint pain and swelling.

Regulatory status

FDA-approved as Sogroya in 2020 for adults and 2023 for children.

Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.

Sources

More in Hormones & metabolism

Somatrogon

FDA-approved
Hormones & metabolism · Ngenla

A weekly long-acting growth hormone for children.

EvidenceFDA approved

Somatropin

FDA-approved
Hormones & metabolism · Genotropin, Norditropin, Omnitrope

Recombinant human growth hormone, a 191 amino acid protein used for growth failure and deficiency.

EvidenceFDA approved

Sermorelin

Wellness and performance
Hormones & metabolism · Geref

A growth hormone-releasing hormone fragment once approved for children and now compounded for adults.

EvidenceSmall human studies
← SermorelinAll peptidesSomatrogon →

General information, not medical advice. Do not buy or inject unregulated peptides.